Astrazeneca Pharma Financials

NSE: ASTRAZEN | BSE: 506820

₹6,153.50

up-down-arrow ₹-14.50 (-0.24%)

As on 18-Nov-2026 14:49IST

Market cap

info icon

₹15,628 Cr

Revenue (TTM)

info icon

₹2,602 Cr

P/E Ratio

info icon

87.9

P/B Ratio

info icon

17.8

Div. Yield

info icon

0.6 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
2,602.07
2,275.58
1,716.29
1,295.53
1,002.97
805.60
Total Income
2,637.50
2,304.07
1,756.92
1,330.33
1,029.07
820.36
Total Expenditure
2,351.82
2,013.55
1,462.32
1,111.08
837.85
719.42
EBITDA
250.25
262.03
253.97
184.45
165.12
86.18
Depreciation
20.02
28.58
39.99
14.94
16.26
16.95
EBIT
230.23
233.45
213.98
169.51
148.86
69.23
Interest
6.94
4.49
1.46
1.20
0.63
0.95
Other Income
35.43
28.49
40.63
34.80
26.10
14.76
Exceptional Items
-14.80
-5.25
-96.79
16.43
-40.23
--
Profit before Tax
243.92
252.20
156.36
219.54
134.10
83.04
Provision for Tax
66.19
64.68
40.62
58.03
34.81
21.44
Profit after Tax
177.73
187.52
115.74
161.51
99.29
61.60

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
878.92
872.79
770.35
711.92
588.69
511.39
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
122.97
394.49
159.13
97.83
68.99
73.63
Current Liabilities
1,189.51
1,109.50
908.15
467.15
484.40
392.30
Total Liabilities
2,191.40
2,414.58
1,879.19
1,298.15
1,162.75
993.62

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
53.64
509.16
290.13
234.16
206.14
212.00
Current Assets
1,936.62
1,859.88
1,547.50
1,042.74
935.94
765.32
Total Assets
2,191.40
2,414.58
1,879.19
1,298.15
1,162.75
993.62
Total Debt*
--
--
--
--
--
--
Net Current Assets
747.11
750.38
639.35
575.59
451.54
373.02
Contingent Liabilities
--
121.23
98.41
137.64
131.62
122.74

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
-15.14
65.36
27.87
58.29
100.80
Cash Flow from Investing Activities
--
18.69
30.80
21.74
18.11
4.74
Cash from Financing Activities
--
-91.97
-65.59
-44.38
-24.48
-9.46
Net Cash Inflow / Outflow
--
-88.42
30.57
5.23
51.92
96.08

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
75.30
75.01
46.30
64.60
39.72
24.64
Cash EPS (₹) info
71.09
86.44
62.29
70.58
46.22
31.42
Adjusted Book Value (₹) info
351.57
346.51
305.28
283.45
234.45
203.78
Dividend per Share (₹) info
0.58
36.00
32.00
24.00
16.00
10.00
Cash Flow per Share (₹) info
--
-6.06
26.14
11.15
23.32
40.32
Free Cash Flow per Share (₹) info
--
-1.96
20.30
15.01
30.74
40.73

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
31.24
21.29
33.94
24.49
17.36
ROE (%) info
21.49
23.02
15.73
24.95
18.13
12.78
ROA (%) info
9.34
8.90
7.43
13.35
9.37
6.65
EBIT Margin (%) info
8.85
10.26
12.47
13.08
14.84
8.59
Net Margin (%) info
6.74
8.14
6.59
12.14
9.65
7.51
Cash Profit Margin (%) info
--
9.47
9.04
13.55
11.47
9.70

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
29.70
32.59
32.48
29.17
24.50
-0.98
EBIT Growth (%) info
-15.90
9.10
26.23
13.87
115.02
-39.98
Net Profit Growth (%) info
-18.93
62.02
-28.34
62.66
61.19
-33.98
EPS Growth (%) info
-10.76
62.02
-28.34
62.66
61.19
-33.98
Book Value Growth (%) info
--
13.51
7.70
20.90
15.05
12.07

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
87.93
103.45
185.90
82.35
81.76
103.71
Price / Book Value info
17.78
22.39
28.19
18.77
13.85
12.54
Dividend Yield (%) info
0.58
0.46
0.37
0.45
0.49
0.39
EV/EBITDA info
52.69
65.23
71.21
58.36
39.84
58.85
Close Price (₹) info
6,186.00
7,765.50
8,607.65
5,328.45
3,252.80
2,551.85
High Price (₹) info
9,850.00
10,691.00
9,059.05
7,220.95
3,620.00
4,580.00
Low Price (₹) info
6,120.50
6,501.60
4,800.15
3,098.00
2,437.75
2,525.95
Market Cap (₹ Cr) info
15,627.50
19,398.64
21,515.93
13,300.95
8,118.24
6,388.65

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
--
--
--
--
Short term debt to equity ratio info
--
--
--
--
--
--
Current Ratio info
1.63
1.68
1.70
2.23
1.93
1.95
Quick Ratio info
0.76
0.75
1.10
1.74
1.54
1.59
Interest Coverage info
36.15
57.17
108.10
183.95
213.86
88.41

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
10.95
9.39
10.77
11.82
10.72
10.66
Asset Turnover info
1.37
1.08
1.11
1.08
0.95
0.87
Receivable days info
--
31.88
35.81
36.53
35.03
38.57
Inventory Days info
--
126.03
82.25
58.60
59.85
67.64
Payable days info
--
163.79
124.39
131.27
214.92
220.48
Cash Conversion Cycle info
--
-5.88
-6.33
-36.14
-120.04
-114.26
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month